Sofosbuvir is a nucleotide analog and direct-acting antiviral agent approved for the treatment of chronic hepatitis C infection. It functions as a prodrug, undergoing intracellular metabolism to form its… Read more









![Chemical structure of L-Alanine, N-[(R)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-methylethyl ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1337529-56-2-L-Alanine-N-R-23456-pentafluorophenoxyphenoxyphosphinyl-1-methylethyl-ester.png&w=3840&q=75)







![Chemical structure of Sofosbuvir 5'-Desphosphate 3'-O-[(S)-Phosphate]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1337482-15-1-Sofosbuvir-5-Desphosphate-3-O-S-Phosphate.png&w=3840&q=75)






























Sofosbuvir is a nucleotide analog and direct-acting antiviral agent approved for the treatment of chronic hepatitis C infection. It functions as a prodrug, undergoing intracellular metabolism to form its active triphosphate metabolite, which inhibits the NS5B RNA-dependent RNA polymerase to terminate viral replication. Laboratories working with this pharmaceutical agent rely on a comprehensive range of Sofosbuvir reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for rigorous quality control, enabling accurate impurity profiling and the development or validation of stability-indicating analytical methods, such as RP-HPLC and LC-MS/MS. Furthermore, these related compounds support forced degradation studies and bioanalytical quantification, ensuring that pharmaceutical development meets stringent regulatory standards. The availability of high-quality, characterized standards facilitates precise monitoring of drug substance consistency and purity throughout the pharmaceutical lifecycle.